Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 19 March 2027
- Last conf. stmt
- 5 March 2026
Chronos Therapeutics Limited
- Incorporated
- 5 March 2009 (17 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Toni Markus Antero HaenninenHuw Jones
- Owned by
- Accounts type
- Total exemption full
- Region
- North West
- Address
- Theracryf Plc Alderley ParkCongleton RoadNether AlderleySK10 4TG
Officers 2 active
Officer details are public data from the Companies House register.
Haenninen, Toni Markus Antero
Director · Appointed 5 April 2024
Finnish
Born December 1977 (48)
Jones, Huw, Dr
Director · Appointed 5 April 2024
British
Born November 1959
Officer history (17 former)
5 April 2024
5 April 2024
Appointed Jones, Huw, Dr as Director
5 April 2024
Appointed Haenninen, Toni Markus Antero as Director
5 April 2024
5 April 2024
30 April 2023
Resigned Hoyer Millar, Christian Gurth as Secretary
30 April 2023
30 April 2023
Resigned Jones, Huw, Dr as Director
30 April 2023
30 April 2023
10 November 2020
27 March 2020
Resigned Towler, Christopher Malcolm, Dr as Director
27 March 2020
Resigned Neave, Frederick as Director
27 March 2020
Resigned Brooksby, Nigel as Director
1 April 2019
Appointed Neave, Frederick as Director
31 March 2019
4 February 2018
1 February 2018
Appointed Brooksby, Nigel as Director
1 February 2018
1 June 2016
1 March 2016
Appointed Hoyer Millar, Christian Gurth as Secretary
4 September 2015
4 June 2015
Appointed Towler, Christopher Malcolm, Dr as Director
4 March 2015
Resigned Mellor, Jane Elizabeth Claire as Director
4 March 2015
1 January 2015
2 April 2014
1 April 2013
Appointed Jones, Huw, Dr as Director
1 January 2013
10 April 2011
3 September 2010
Appointed Mellor, Jane Elizabeth Claire as Director
27 May 2010
Resigned Harper, Paul, Dr as Director
1 November 2009
Appointed Harper, Paul, Dr as Director
1 May 2009
5 March 2009
5 March 2009
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 5 April 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 09246681
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Chronos Therapeutics Limited This company Owns 75–100% of shares
Theracryf Pharma Ltd Owns 75–100% of shares
Financials
Balance sheet as at 31 March 2025 · total exemption full accounts
- Cash
- £37,645
- Current Ratio
- 0.2x
Trend
Shareholder Funds
Balance sheet detail
| 2025 | 2024 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fixed Assets | £605,256 | £641,389 | £1,164,672 | ||
| Current Assets | £58,098 | £21,109 | £143,372 | £219,238 | £908,127 |
| Debtors | £20,453 | £11,698 | £5,907 | £110,214 | £324,752 |
| Cash | £37,645 | £9,411 | £137,465 | £109,024 | £583,375 |
| Creditors (< 1 year) | £341,924 | £165,628 | £11,576 | £17,462 | £205,112 |
| Net Current Assets | (£283,826) | (£144,519) | £131,796 | £201,776 | £703,015 |
| Shareholder Funds | £159,084 | £359,644 | £737,052 | £843,165 | £1,867,687 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 5 March 2026 | Confirmation statement with no updates | 5 March 2026 | ||
| 25 February 2026 | Director's details changed | |||
| 7 November 2025 | Total exemption full accounts | 31 March 2025 | ||
| 8 April 2025 | Confirmation statement with updates | 5 March 2025 | ||
| 28 March 2025 | Withdrawal of a person with significant control statement |
Other companies in this industry
Oxford
Cambridge
Coventry
Weybridge
Stevenage
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →